STAT+: PBMs face scrutiny from all sides, and analyzing Marty Makary's road to the FDA

Comments
Loading...

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Congress nears spending deal with long-awaited PBM reforms

Congress is on the edge of a deal that would reshape pharmacy benefit managers, extend telehealth access, and renew certain public health authorities.

The language of the government funding package has not been publicly released as of Monday night and could still change, but sources indicate some longtime health care policy priorities are making the cut for the year-end spending deal, Rachel Cohrs Zhang reports.

Continue to STAT+ to read the full story…

Market News and Data brought to you by Benzinga APIs

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!